19-54250868-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000449561.3(LILRB5):c.1694G>A(p.Arg565Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,612,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R565P) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000449561.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LILRB5 | NM_001081442.3 | c.1694G>A | p.Arg565Gln | missense_variant | 13/13 | ENST00000449561.3 | NP_001074911.2 | |
LILRB5 | NM_001304457.3 | c.1904G>A | p.Arg635Gln | missense_variant | 13/13 | NP_001291386.2 | ||
LILRB5 | NM_006840.5 | c.1691G>A | p.Arg564Gln | missense_variant | 13/13 | NP_006831.2 | ||
LILRB5 | NM_001081443.3 | c.1394G>A | p.Arg465Gln | missense_variant | 12/12 | NP_001074912.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LILRB5 | ENST00000449561.3 | c.1694G>A | p.Arg565Gln | missense_variant | 13/13 | 1 | NM_001081442.3 | ENSP00000406478.1 |
Frequencies
GnomAD3 genomes AF: 0.0000865 AC: 13AN: 150248Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251442Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135908
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461788Hom.: 0 Cov.: 32 AF XY: 0.0000358 AC XY: 26AN XY: 727202
GnomAD4 genome AF: 0.0000865 AC: 13AN: 150248Hom.: 0 Cov.: 31 AF XY: 0.0000956 AC XY: 7AN XY: 73242
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 15, 2024 | The c.1694G>A (p.R565Q) alteration is located in exon 13 (coding exon 13) of the LILRB5 gene. This alteration results from a G to A substitution at nucleotide position 1694, causing the arginine (R) at amino acid position 565 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at